Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(7)
•••
Comment by stjjmacon Jan 09, 2019 6:18pm
194 Views
Post# 29209287

RE:RE:RE:Explain please .. Confused

RE:RE:RE:Explain please .. Confused
sonofabach wrote: Garth did nothing "perfectly" about this merger - .34 per share is far from what he had hoped and sold during his years of promotion.

Agreed the company is far stronger now than before and will very likely grow much better combined now that we have a better management team to see us into 2020


agreed, and to be clear there was NO premium]

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities